Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 35947813

Development and Validation of Risk Prediction Models for Coronary Heart Disease and Heart Failure After Treatment for Hodgkin Lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2023 Jan 1
First author
de Vries S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      de Vries S
      type
      Author
    2. name
      Haaksma ML
      type
      Author
    3. name
      Jóźwiak K
      type
      Author
    4. name
      Schaapveld M
      type
      Author
    5. name
      Hodgson DC
      type
      Author
    6. name
      Lugtenburg PJ
      type
      Author
    7. name
      Krol ADG
      type
      Author
    8. name
      Petersen EJ
      type
      Author
    9. name
      van Spronsen DJ
      type
      Author
    10. name
      Ahmed S
      type
      Author
    11. name
      Hauptmann M
      type
      Author
    12. name
      Aleman BMP
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      de Vries S
      type
      Author
    2. name
      Haaksma ML
      type
      Author
    3. name
      Jóźwiak K
      type
      Author
    4. name
      Schaapveld M
      type
      Author
    5. name
      Hodgson DC
      type
      Author
    6. name
      Lugtenburg PJ
      type
      Author
    7. name
      Krol ADG
      type
      Author
    8. name
      Petersen EJ
      type
      Author
    9. name
      van Spronsen DJ
      type
      Author
    10. name
      Ahmed S
      type
      Author
    11. name
      Hauptmann M
      type
      Author
    12. name
      Aleman BMP
      type
      Author
    bibliography ids
    1. nci-bib-07420aa978f315e879cc677b
    book metadata
    content sha256
    2a4648526631100b30931bee2157187a3a4321cd944075f101acbec55cb200f8
    document type
    citation
    dois
    1. 10.1200/JCO.21.02613
    electronic publication date
    display
    2022 Aug 10
    precision
    day
    year
    2022
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:35947813
    immutable id
    pubmed:35947813@2a4648526631100b30931bee2157187a3a4321cd944075f101acbec55cb200f8
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    1
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    86-95
    volume
    41
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      35947813
      provenance
      batch id
      9d150d55960e0c12aada
      provider
      NCBI PubMed ESummary
      record sha256
      2af169e2c22c31c23962f3178be1181105f9b7e072fa99776f3422b064e255cd
      response sha256
      2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
      retrieved at
      2026-09-09T23:48:09.820498+00:00
      publication date
      display
      2023 Jan 1
      precision
      day
      year
      2023
      publication types
      1. Multicenter Study
      2. Journal Article
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/35947813/
      title
      Development and Validation of Risk Prediction Models for Coronary Heart Disease and Heart Failure After Treatment for Hodgkin Lymphoma.

      Preserved source evidence · Not medical advice